Sign Up to like & get
recommendations!
0
Published in 2017 at "Bone Marrow Transplantation"
DOI: 10.1038/bmt.2017.193
Abstract: Donor-lymphocyte infusion (DLI) for relapse following haploidentical hematopoietic cell transplantation (haploHCT) with post-transplant cyclophosphamide (PTCy) has been described in recipients of bone marrow grafts, but not recipients of G-CSF mobilized peripheral blood (PB) grafts. We…
read more here.
Keywords:
dli;
lymphocyte infusion;
relapse;
transplantation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000001789
Abstract: The therapeutic approach for relapsed/refractory acute lymphoblastic leukemia (ALL) remains to be a challenge. The patient was diagnosed as B-cell ALL at 6 months of age and relapsed for the second time following repeat allogeneic…
read more here.
Keywords:
blinatumomab;
therapy;
lymphocyte infusion;
donor lymphocyte ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.554503
Abstract: Prophylactic donor lymphocyte infusion (pDLI) could reduce relapse in patients with refractory/relapsed acute leukemia (RRAL) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but optimal timing of pDLI remains uncertain. We compared the outcomes of two…
read more here.
Keywords:
lymphocyte infusion;
cohort;
donor lymphocyte;
day ... See more keywords